Newsletters

Drug Pricing

President Joe Biden speaks about Medicare
Congressional Politics

Medicare-Eligible Population Backs Biden’s Plan to Cut Beneficiaries’ Costs, Address Solvency

Children

Voters Mostly Support Biden’s 2024 Budget Proposal

Joe manchin speaking on the inflation reduction act
Affordable Care Act

Unpacking Voters’ Perceptions of the Inflation Reduction Act

Image of Sen. Joe Manchin
Affordable Care Act

Most Voters Back ACA Subsidy Extensions, Say They're Important to Lower Costs

2022 Elections

Democrats’ Drug Pricing and Medicare Plans Garner Broad Bipartisan Voter Support

Drug Pricing

Incoming PhRMA Chair Expects Drugmakers to Face ‘Some Pain’ in 2022 Amid Reform and Efforts to Rebuild Patient Trust

Congressional Politics

As Senate Negotiates Build Back Better Act, Voters View Health Measures as Its Most Important Pieces

Drug Pricing

Half of Voters Support Plan to Let Medicare Negotiate Drug Prices

Congressional Politics

Pharmacy Benefit Managers Are Feeling a Push From States to ‘Turn the Lights on’ to Their Business Practices

Congressional Politics

Expanding Access to Biosimilars Has Bipartisan Support. But Movement on Legislation Hangs in the Balance of the Drug Pricing Debate

Congressional Politics

Curbing Drug Costs Should Be a Top Priority for Congress, 1 in 2 Voters Say

COVID-19

About 2 in 5 Voters Say Passing a Health Care Reform Bill Should Be a Top Priority for Biden’s First 100 Days

AboutCareersMorning Consult IntelligenceCustom Research IntelligenceRequest a Demo
© 2023 Morning Consult, All Rights Reserved. The M Logo and MORNING CONSULT are registered trademarks of Morning Consult Holdings, Inc.
Privacy PolicySecurityDo Not Sell or Share My Personal Information California Privacy Notice